Download Files:
Products Details
Product Description
– GSK2818713 is a novel Hepatitis C NS5A replication complex inhibitor.
Web ID
– HY-145335
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C46H56N8O8
References
– [1]Kazmierski WM, et al. GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage. J Med Chem. 2020 Apr 23;63(8):4155-4170.
CAS Number
– 1422484-32-9
Molecular Weight
– 848.99
SMILES
– O=C(N1[C@](C[C@@]2([H])[C@]1([H])CCC2)([H])C3=NC=C(N3)C4=CC5=C(C=CC(C6=CN=C([C@@](C[C@@]7([H])[C@]8([H])CCC7)([H])N8C([C@H]([C@@H](C)OC)NC(OC)=O)=O)N6)=C9)C9=C5C=C4)[C@H]([C@@H](C)OC)NC(OC)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HCV Protease
Pathway
– Anti-infection;Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
